WilmerHale Advises Thermo Fisher Scientific in €1.6B Eurobond Public Offering

WilmerHale Advises Thermo Fisher Scientific in €1.6B Eurobond Public Offering

News

Thermo Fisher Scientific Inc., a provider of equipment, software and services for research, manufacturing, analysis, discovery and diagnostics, announced the completion of its public offering of  €1 billion aggregate principal amount of 0.750% Senior Notes due 2024 and €600 million aggregate principal amount of 1.375% Senior Notes due 2028 at the issue prices of 99.122% of the principal amount and 99.748% of the principal amount, respectively. The offering closed on September 12, 2016.

The WilmerHale team was led by Partner Knute Salhus and included Partners John Sigel, Julie Hogan Rodgers, Tim Silva, Senior Associate Ryan Mitteness, and Associates Tim Hultzman and Seth Davis.

For more information, read Thermo Fisher Scientific's press release.